Lusitropic effect of MCC-135 is associated with improvement of sarcoplasmic reticulum function in ventricular muscles of rats with diabetic cardiomyopathy

Journal of Pharmacology and Experimental Therapeutics

Volumn 298, Issue 3, 2001, Pages 1161-1166

  Satoh, Naoya ^a   Sato, Taku ^a   Shimada, Mayumi ^a   Yamada, Kumi ^a   Kitada, Yoshimi ^a  

^a Mitsubishi Pharma Corporation   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALDARET; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; ISOPRENALINE; MCC 135; SAPONIN; STREPTOZOCIN; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CARDIOMYOPATHY; CELL FUNCTION; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG STRUCTURE; HEART VENTRICLE CONTRACTION; HEART VENTRICLE WALL; MALE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RAT; SARCOPLASMIC RETICULUM;

ANIMALS; BENZENESULFONATES; CALCIUM; CALCIUM-BINDING PROTEINS; CALCIUM-TRANSPORTING ATPASES; CARDIOMYOPATHIES; DIABETIC ANGIOPATHIES; HEART; HEART VENTRICLES; MALE; MUSCLE PROTEINS; MYOCARDIAL CONTRACTION; MYOCARDIUM; PAPILLARY MUSCLES; PIPERAZINES; RATS; RATS, WISTAR; SARCOPLASMIC RETICULUM;

EID: 0034889211     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure
2. Calcium fluxes involved in control of cardiac myocyte contraction
3. Influence of experimental diabetes on sarcoplasmic reticulum function in rat ventricular muscle
4. Functional alterations in adult rat myocytes after overexpression of phospholamban with use of adenovirus
5. Altered contractile function in heart failure
6. Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a
7. Adenovirus-based phospholamban antisense expression as a novel approach to improve cardiac contractile dysfunction: Comparison of a constitutive viral versus an endothelin-1-responsive cardiac promoter
8. Specific perforation of muscle cell membranes with preserved SR functions by saponin treatment
9. 2+ATPase and phospholamban mRNA and protein levels in end-stage heart failure due to ischemic or dilated cardiomyopathy
10. 2+-ATPase activity and expression in ventricular myocardium of dogs with heart failure
11. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
12. Calcium handling proteins in the failing human heart
13. Noninvasive evaluation of cardiac dysfunction by echocardiography in streptozotocin-induced diabetic rats
14. 2+ handling in streptozotocin-induced diabetic rat myocardium
15. Pharmacology of the cardiac sarcoplasmic reticulum calcium ATPase-phospholamban interaction
16. 2+ATPase activity by MCC-135 is associated with the improvement of depressed contractile function in canine post-ischemic myocardium
17. ++ sensitivity of the contractile system by MCI-154, a novel cardiotonic agent, in chemically skinned fibers from the guinea pig papillary muscles
18. 2+ handling in ventricular myocytes isolated from diabetic rats
19. Decreased sensitivity of contraction to changes of intracellular pH in papillary muscle from diabetic rat hearts
20. Phosphorylation of phospholamban and troponin I in beta-adrenergic-induced acceleration of cardiac relaxation
21. Abnormal cardiac function in the streptozotocin-diabetic rat. Changes in active and passive properties of the left ventricle
22. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation
23. 2+ transport in streptozotocin-induced diabetic cardiomyopathy in rats
24. Adrenergic effects on the biology of the adult mammalian cardiocyte
25. The effect of a novel cardioprotector AAA-135 on the morphology and function in a viral model of cardiomyopathy
26. Diabetes rapidly induces contractile dysfunctions in isolated ventricular myocytes
27. 2+-pump ATPase of the diabetic rat heart by lipid-lowering interventions
28. 2+-handling modulator MCC-135 improves left ventricular function and reduces mortality in cardiomyopathic hamsters
29. Chronic alpha-adrenergic receptor stimulation modulates the contractile phenotype of cardiac myocytes in vitro
30. Human heart failure: cAMP stimulation of SR Ca(2+)-ATPase activity and phosphorylation level of phospholamban
31. 2+-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts
32. 2+ sensitivity of SERCA 2a in failing human myocardium due to reduced serin-16 phospholamban phosphorylation
33. Differences in mechanisms of SR dysfunction in ischemic vs. idiopathic dilated cardiomyopathy
34. Effects of cyclopiazonic acid on rat myocardium: Inhibition of calcium uptake into sarcoplasmic reticulum
35. 2+ current in diabetic rat cardiomyocytes
36. 2+ Channel mRNA in streptozotocin-induced diabetic rat heart
37. 2+ currents in ventricular myocytes from rats with chronic diabetes
38. Effects of moderate diabetes on cardiac performance in spontaneously hypertensive and Wistar-Kyoto rats
39. 2+ leak through ryanodine receptor in heart failure
40. Regulation of alpha 1-, beta 1-, and beta 2-adrenergic receptors in rat heart by norepinephrine